Intensity Therapeutics, Inc. - INTS
About Gravity Analytica
Recent News
- 02.13.2026 - Intensity Therapeutics Announces Reverse Stock Split
- 01.13.2026 - Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities
- 12.11.2025 - Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium
- 12.05.2025 - Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
- 12.04.2025 - Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium
- 11.06.2025 - Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
- 10.31.2025 - Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock
Recent Filings
- 01.23.2026 - S-8 Securities to be offered to employees in employee benefit plans
- 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
- 12.05.2025 - EX-99.1 EX-99.1
- 12.05.2025 - 8-K Current report
- 12.04.2025 - 424B5 Prospectus [Rule 424(b)(5)]
- 12.04.2025 - 8-K Current report
- 11.06.2025 - EX-99.1 EX-99.1
- 11.06.2025 - 8-K Current report
- 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]